Clinical Trial Update: Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating paclitaxel plus capecitabine in patients with metastatic or recurrent esophageal cancer. The current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN